Search research articles
Contact Us
Filters
Showing results (61-70 of 379) with videos related to
Page
of 38
Sort By:
Endocrine
|
May 18, 2022
FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma
Mariangela Tamburello, Barbara Altieri, Iuliu Sbiera, et al.
The Oncologist
|
August 13, 2011
Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review
Consuelo Buttigliero, Chiara Monagheddu, Paola Petroni, et al.
Journal of Oncology
|
May 7, 2019
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma
Chiara Fiorentini, Salvatore Grisanti, Deborah Cosentini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2016
Serum Vitamin D and Prostate Cancer Prognosis: The Story Continues
Elisa Roca, Francesca Valcamonico, Vito Amoroso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2014
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer?
Francesca Valcamonico, Fausto Petrelli, Laura Ferrari, et al.
Expert Review of Anticancer Therapy
|
August 18, 2018
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options
Soraya Puglisi, Paola Perotti, Deborah Cosentini, et al.
Current Treatment Options in Oncology
|
November 18, 2023
The Evolving Treatment Landscape of Medullary Thyroid Cancer
Marta Laganà, Valentina Cremaschi, Andrea Alberti, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 18, 2022
Letter to the Editor From Cosentini et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival"
Deborah Cosentini, Marta Laganà, Antonella Turla, et al.
The American Journal of Surgical Pathology
|
June 11, 2010
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior
Mauro Papotti, Marco Volante, Eleonora Duregon, et al.
Drugs & Aging
|
December 24, 2002
Background to and management of treatment-related bone loss in prostate cancer
Alfredo Berruti, Marcello Tucci, Carlo Terrone, et al.
Page
of 38
Search research articles
Search
Showing results (61-70 of 379) with videos related to
Sort By:
Page
of 38
Endocrine
|
May 18, 2022
FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma
Mariangela Tamburello, Barbara Altieri, Iuliu Sbiera, et al.
The Oncologist
|
August 13, 2011
Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review
Consuelo Buttigliero, Chiara Monagheddu, Paola Petroni, et al.
Journal of Oncology
|
May 7, 2019
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma
Chiara Fiorentini, Salvatore Grisanti, Deborah Cosentini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2016
Serum Vitamin D and Prostate Cancer Prognosis: The Story Continues
Elisa Roca, Francesca Valcamonico, Vito Amoroso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2014
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer?
Francesca Valcamonico, Fausto Petrelli, Laura Ferrari, et al.
Expert Review of Anticancer Therapy
|
August 18, 2018
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options
Soraya Puglisi, Paola Perotti, Deborah Cosentini, et al.
Current Treatment Options in Oncology
|
November 18, 2023
The Evolving Treatment Landscape of Medullary Thyroid Cancer
Marta Laganà, Valentina Cremaschi, Andrea Alberti, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 18, 2022
Letter to the Editor From Cosentini et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival"
Deborah Cosentini, Marta Laganà, Antonella Turla, et al.
The American Journal of Surgical Pathology
|
June 11, 2010
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior
Mauro Papotti, Marco Volante, Eleonora Duregon, et al.
Drugs & Aging
|
December 24, 2002
Background to and management of treatment-related bone loss in prostate cancer
Alfredo Berruti, Marcello Tucci, Carlo Terrone, et al.
Page
of 38